Sydney Health Literacy Lab, School of Public Health, The University of Sydney, Sydney, New South Wales, Australia
Sydney Health Literacy Lab, School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
BMJ Open. 2020 Jul 13;10(7):e039041. doi: 10.1136/bmjopen-2020-039041.
To explore women's experiences of the renewed National Cervical Screening Program in Australia from the perspective of women who have received different human papillomavirus (HPV) test results. Women aged 25 to 74 are now screened every 5 years with primary HPV screening.
Qualitative interview study.
Australia.
Women in Australia aged 25 to 74 who reported participating in cervical screening since December 2017, purposively sampled by test result (HPV positive, HPV negative and HPV status unknown).
26 interviews with women aged 25 to 74 were conducted and analysed thematically.
Three main themes emerged: knowledge and attitudes about the programme changes, information dissemination, the meaning and responses to test results and the new cervical screening test (CST). Some women showed little awareness of the changes, but others understood that HPV is detected earlier than abnormal cells. Some expressed positive attitudes towards the CST and were not anxious about less frequent screening. Most women envisaged the changes would have minimal impact on their screening behaviour. Women mainly wanted more information about the changes and the possible results from the new CST. Overall women could recall their HPV results and understand the implications for future cervical screening. Anxiety about being at 'increased risk' was more apparent in women who were HPV positive without history of abnormal results.
Women show some understanding of HPV and the new CST, but more written and public communication about the changes and possible results are warranted. Efforts are needed to ensure that women who are HPV positive without history of abnormal results receive the information needed to alleviate anxiety.
从接受不同人乳头瘤病毒（HPV）检测结果的女性的角度探讨澳大利亚更新后的国家宫颈癌筛查计划的女性体验。现在，年龄在 25 至 74 岁的女性每 5 年进行一次 HPV 初筛。
定性访谈研究。
澳大利亚。
自 2017 年 12 月以来，年龄在 25 至 74 岁的澳大利亚女性报告参加了宫颈癌筛查，通过测试结果（HPV 阳性、HPV 阴性和 HPV 状态未知）进行有针对性的抽样。
对 25 至 74 岁的女性进行了 26 次访谈，并对其进行了主题分析。
出现了三个主要主题：对项目变化的知识和态度、信息传播、对检测结果的意义和反应以及新的宫颈癌筛查试验（CST）。一些女性对变化知之甚少，但另一些女性则明白 HPV 比异常细胞更早被检测出来。一些人对 CST 持积极态度，对较少的频繁筛查不感到焦虑。大多数女性预计这些变化对其筛查行为的影响最小。女性主要希望获得更多有关变化和新 CST 可能结果的信息。总的来说，女性可以回忆起自己的 HPV 结果，并理解对未来宫颈癌筛查的影响。对处于“高风险”的焦虑在 HPV 阳性且无异常结果史的女性中更为明显。
女性对 HPV 和新 CST 有一定的了解，但需要更多有关变化和可能结果的书面和公开沟通。需要努力确保没有异常结果史的 HPV 阳性女性获得缓解焦虑所需的信息。
